Table 1.
Baseline characteristics.
| Patients | n = 50 |
|---|---|
| Age | |
| 18-28 | 4 (8%) |
| 29-39 | 12 (24%) |
| 40-50 | 7 (14%) |
| 51-61 | 12 (24%) |
| 62-72 | 9 (18%) |
| 73-83 | 6 (12%) |
| Sex | |
| Men | 23 (46%) |
| Women | 27 (54%) |
| ECOG Score | |
| < 1 | 50 (100%) |
| Histological type | |
| Undifferentiated Pleomorphic Sarcoma | 3 (6%) |
| Spindle cell sarcoma | 2 (4%) |
| Leiomyosarcoma, uterine = 8 (16%) | 15 (30%) |
| Leiomyosarcoma, Non-uterine = 7 (14%) | |
| Sacral chordoma | 1 (2%) |
| Osteosarcoma | 4 (8%) |
| Ewing sarcoma | 2 (4%) |
| Clear cell sarcoma | 1 (2%) |
| Extraskeletal myxoid chondrosarcoma | 1 (2%) |
| Synovial sarcoma | 8 (16%) |
| Desmoplastic small round cell tumor | 1 (2%) |
| Epithelioid sarcoma | 1 (2%) |
| Rhabdomyosarcoma | 1 (2%) |
| Liposarcoma, dedifferentiated = 4 (8%) | 8 (16%) |
| Liposarcoma, myxoid = 4 (8%) | |
| Carcinosarcoma | 1 (2%) |
| Myoepithelioma | 1(2%) |
| Number of chemotherapy regimens | |
| Intention-to-Treat: median (range) | 4 (range: 1-11) |
| Modified Intention-to-Treat: median (range) | 3 (range: 1-11) |